Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2004Journal of Clinical InvestigationOpen Access

Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype

View Full Paper
Ask AI
Bookmark
Share

Authors

DBDiane R. BielenbergBoston Children's HospitalYHYasuhiro HidaFujita Health UniversityASAkio ShimizuSoka University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bielenberg et al. (2004) studied this question.

synapsesocial.com/papers/6a7277a8febe604dd70a9fbchttps://doi.org/10.1172/jci21378
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Human Melanoma Line Heterogeneous With Respect to Metastatic Capacity in Athymic Nude Mice 2 3 41984 · 231 citations
  2. 2Inhibition of Vascular Endothelial Growth Factor (VEGF)-induced Endothelial Cell Proliferation by a Peptide Corresponding to the Exon 7-Encoded Domain of VEGF1651997 · 202 citations
  3. 3Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish2002 · 215 citations
  4. 4Abnormal lymphatic vessel development in neuropilin 2 mutant mice2002 · 634 citations
  5. 5Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity2000 · 313 citations